SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens IMDELLTRAIMFINZI combination is drawing attention after Phase 3 results showed a substantial survival benefit in first-line small-cell lung cancer, strengthening discussion of the companys oncology pipeline. Traders are also citing Repathas strong sales growth, while weighing those growth drivers against biosimilar pressure.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

IEP is drawing attention after a sharp selloff that traders say lacks an obvious fresh headline; speculation includes short-selling or positioning, while others worry about the distribution, debt obligations, and portfolio decisions. The cause of the decline remains uncertain, and some holders are waiting for earnings or management updates for clarity.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarnas steep selloff is being linked by traders to reduced growth guidance amid weakness in Germany and heavier investment, with frustration over the stocks persistent underperformance. Bulls argue that improving profitability and expansion through Apple, JPMorgan and other partnerships could support longer-term growth, while skeptics remain concerned about execution and returns.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

A broad cybersecurity rally tied to headlines about AI-discovered software vulnerabilities is lifting Zscaler, with traders viewing expanding AI-related risks as a potential tailwind for security spending. Bulls point to breakout momentum and possible short covering, while some caution the stock may be overextended.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Reports of a possible AstraZenecaBristol Myers Squibb merger sparked debate over financing, dilution and integration risks, with traders linking the speculation to pressure on AZN shares. Subsequent reports that no talks had taken place eased some concerns, though the merger chatter remains unconfirmed.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Attention centers on Heluss pivotal Phase 3 APPROACH readout for HLP003, its investigational add-on treatment for major depressive disorder, expected in Q4 2026. Bulls point to earlier Phase 2 results and the option for patients to remain on antidepressants, while skeptics emphasize the binary trial risk and potential financing-related dilution.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

A sustained selloff has intensified debate over Carvanas financing-dependent business, with traders citing credit quality, debt, higher borrowing costs, and used-car market pressure as risks ahead of Q3 results. Bears see further downside, while some bulls expect a rebound or short-covering move; no specific new catalyst is consistently confirmed.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is drawing attention amid a sharp, volatile selloff in bitcoin miners and AI data-center stocks, as traders weigh Bitcoin weakness, financing costs and concerns about execution of the companys data-center pivot. The debate pits fears over capital needs and delayed returns against confidence in its longer-term AI infrastructure opportunity and upcoming earnings update.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons breakout to fresh highs, alongside rising crude prices and geopolitical supply concerns, is driving attention as traders position around the upcoming earnings report. The community is broadly bullish on the momentum, though some see the report and elevated oil-driven expectations as risks to sustaining the advance.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Traders are focused on SNOWs rebound after a sharp pullback, with bullish options positioning and attention to whether support holds. Some see room for further recovery on Snowflakes growth story, while skeptics question its valuation and whether the bounce will last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today

Oscar Health, Inc. (OSCR) concluded the recent trading session at $30.99, signifying a -6.99% move from its prior day's close.

Oscar Introduces a New Wave of Consumer Health Products

Oscar Insurance, one of the fastest-growing insurers in the individual market and part of Oscar Health, Inc. (NYSE: OSCR), today unveiled its 2027 health insurance lineup for millions of consumers during the open enrollment period. Oscar is entering South Carolina and expanding its footprint to 713...

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?

Oscar Health outshines Molina Healthcare with surging membership, stronger earnings growth prospects, a more attractive valuation and robust stock gains.

Are Finance Stocks Lagging  ASX Limited - Unsponsored ADR (ASXFY) This Year?

Here is how ASX Limited - Unsponsored ADR (ASXFY) and Oscar Health, Inc. (OSCR) have performed compared to their sector so far this year.

Zacks Investment Ideas feature highlights: CoreWeave, Cinemark, Oscar Health and Heico

Cinemark, Oscar Health and Heico stand out amid market turmoil, with rising earnings estimates, strong fundamentals and constructive price action.

Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $33.47, representing a -2.48% change from its previous close.

3 Top Ranked Stocks Gaining Despite Market Turmoil

Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader market.

Best Growth Stocks to Buy for October 15th

WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13,52026.

Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $34.32, indicating a +1.57% shift from the previous trading day.

Oscar Health, Inc. (OSCR) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Bertolini said the insurer is talking with Hims about selling retail drugs through Lucie.</li><li>Lucie lets consumers compare insurance plans, supplemental benefits and cash-pay healthcare services.</li><li>Oscar believes Lucie can target over 200 million lives, potentially creating a new distribution channel for Hims.</li></ul>Shares of Hims &amp; Hers (HIMS) climbed 0.2% overnight late Sunday after Oscar Health CEO Mark Bertolini revealed that the insurer is talking to the digital-health company about offering retail drugs through its new Lucie consumer marketplace.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> fell 2% on Friday, extending losses for the week to 11%.&nbsp;<h2 class="st-heading-2">Oscar Courts Hims For Retail Drugs</h2>Oscar launched Lucie Health Marketplace in April as an AI-powered storefront where consumers and brokers can compare individual-market insurance plans from multiple carriers, including Oscar’s competitors, alongside supplemental benefits and cash-pay services. The platform is primarily for Individual Coverage Health Reimbursement Arrangements (ICHRAs), through which employers give workers money to select their own health coverage.Employees could use funds remaining after premiums to cover out-of-pocket expenses or purchase dental, ancillary and retail-health products. Aflac and Allstate Health are already on the marketplace.“People that want to sell retail drugs — we’re talking to Hims, we’re talking to all these other players,” Bertolini said over a weekend&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=uNxDvhCdnLI">interview</a>. Oscar wants to build a marketplace where consumers can compare healthcare products based on “convenience and cost and value,” he added.<h2 class="st-heading-2">Oscar Eyes Hims For GLP-1 Access&nbsp;</h2>Bertolini specifically identified GLP-1 weight-loss drugs as a potential use case. He was talking about consumers shopping through Lucie for a GLP-1 that is not covered by their insurance, using employer-provided funds to compare the lowest cash prices from Hims, Mark Cuban’s drug business or other sellers.Using an uncovered GLP-1 as an example, Bertolini said consumers could turn to the marketplace to determine: “Where can I get that cheapest?” The model aligns with Hims’ direct-to-consumer platform, which combines access to medications with providers, pharmacies and ongoing care.Hims CEO Andrew Dudum said on the company’s latest second-quarter call that an expanded selection of branded weight-loss treatments helped reaccelerate U.S. growth. He also called the company’s relationship with Novo Nordisk “extremely” exciting and called demand for the Wegovy pill “staggering.” “We are the largest or one of the largest players that are helping people access that pill,” Dudum said, adding that the launch opened the “floodgates” for patients concerned about injections and pricing.<h2 class="st-heading-2">Oscar’s Lucie Bet Targets 200M Lives&nbsp;</h2>Oscar currently operates primarily in the Affordable Care Act individual market, which Bertolini estimated at 40 million people. Through ICHRA, Lucie and related offerings, he sees an opportunity spanning small and midsized businesses, gig workers, part-time employees, entrepreneurs and early retirees.“The individual market will be the ultimate market for all Americans,” Bertolini said. “The TAM will be over 200 million lives.” Inclusion in Lucie could give Hims an additional distribution channel by placing its medications before consumers actively shopping for healthcare. However, Oscar has not disclosed how many users Hims could potentially reach. Bertolini said Oscar’s emerging non-insurance business could generate a 36% margin and become “bigger for all of us than anything we do on the insurance side.”<h2 class="st-heading-2">How Do Retail Traders Feel About HIMS?</h2>On Stocktwits, retail sentiment for HIMS improved to ‘bullish’ from ‘neutral’ levels a week ago amid ‘high’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/hims_ss_b7b1169c7d.png" alt="hims ss.png" width="967" height="131"><figcaption>HIMS sentiment and message volume as of August 16 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/finestructure/message/662023170">said</a>, “$HIMS Definitely under 25 short time. Maybe 13 longer, who knows. Well somebody knows.”<stembedurl>https://stocktwits.com/finestructure/message/662023170</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/bullishoverbears/message/662016981">said</a>, “<a href="https://stocktwits.com/symbol/HIMS">$HIMS</a> big week Hims bulls. $27.50-28.20 needs to hold otherwise $24-25 is coming this week. A hold of 28 support gives us a retest of $30-32”<stembedurl>https://stocktwits.com/bullishoverbears/message/662016981</stembedurl>HIMS stock has declined 40% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nio-morningstar-2027-profit-china-ev-price-war/cZo6nziRJKX">NIO Stock Suffers Worst Run In 3 Weeks — Morningstar Sees 2027 Profit Even As China EV Price War Rages&nbsp;</a>

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS). (Photo illustration by Cheng Xin/Getty Images)

Oscar Health CEO Mark Bertolini identified uncovered GLP-1 drugs as a potential use case for Hims on the marketplace.

Hims & Hers Health Inc

OSCR health stock price, news, financials, forum, discussion, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

OSCR Health Stock Price Today, News, Analysis and Trading Ideas

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

OSCR News